Fusion genes are crucial in cancer research because they can serve as both diagnostic markers and therapeutic targets. The presence of specific fusion genes can help in identifying the type of cancer, determining prognosis, and selecting appropriate treatment options. For example, the BCR-ABL fusion gene is a hallmark of chronic myeloid leukemia (CML) and can be targeted by specific inhibitors.
